{{Rsnum
|rsid=6028466
|Chromosome=20
|position=39500359
|Orientation=plus
|GMAF=0.101
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 12.4 | 87.6
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.9 | 8.0 | 91.2
| YRI | 6.1 | 46.3 | 47.6
| ASW | 8.8 | 28.1 | 63.2
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 10.9 | 89.1
| LWK | 7.3 | 38.2 | 54.5
| MEX | 0.0 | 10.3 | 89.7
| MKK | 3.8 | 38.5 | 57.7
| TSI | 1.0 | 18.6 | 80.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21460395
|Trait=None
|Title=A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer
|RiskAllele=
|Pval=3E-7
|OR=0.1900
|ORtxt=[NR] unit increase
|OA=1
}}

{{PMID Auto
|PMID=23180556
|Title=Leukocyte telomere length-related genetic variants in 1p34.2 and 14q21 loci contribute to the risk of esophageal squamous cell carcinoma
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}